Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Initiator Pharma has completed first dosing of the re-started Phase I study with IPED2015

Initiator Pharma A/S, a biotech company that is developing a novel treatment of erectile dysfunction today announced that it has completed first dosing of the re-started Phase I study.The first healthy subjects have been dosed in re-start of the Phase I, SAD study with IPED2015. No relevant adverse clinical events or signs were recorded during the post-dosing observation period. There were no changes of any significance seen in any of the cardiac telemetry. All blood tests so far have been normal. The amended protocol has been discussed and approved by the relevant Authorities and Ethics

Q3 report 2018

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.  +--------------------------------------------+|Third Quarter (2018-07-01 – 2018-09-30) |+--------------------------------------------+| || · Net revenues were TDKK 0 (0) || · EBIT was TDKK -3,699 (-2,464) || · Earnings per share was DKK –0.21 (-0.29)|+--------------------------------------------+|

FLEX LNG LTD. – APPROVAL AND PUBLICATION OF PROSPECTUS

FLEX LNG LTD. – APPROVAL AND PUBLICATION OF PROSPECTUS The Norwegian Financial Supervisory Authority (Nw. Finanstilsynet) has approved the prospectus of FLEX LNG Ltd. (the “Company”) relating to the listing of 172,938,947 new shares in the Company (the “Shares”), issued in a private placement completed on 11 October 2018 (the “Private Placement”). The Shares will become registered on the Company’s ordinary ISIN BMG359471031 following approval of the prospectus and become freely tradable on Oslo Børs under the trading symbol “FLNG” at the same time. For more information, please

Caverion to sell the project piping and tank business and the related Ylivieska workshop of the Industrial Solutions division to a Swedish private equity investor

Caverion Corporation Investor news 23 November 2018 at 9.30 a.m. EETCaverion to sell the project piping and tank business and the related Ylivieska workshop of the Industrial Solutions division to a Swedish private equity investor Caverion has signed an agreement to sell the project piping and tank business and the related Ylivieska workshop of the Industrial Solutions division to Mimir Invest. The buyer is a Swedish private equity investor. “This asset sale is a continuum to our exits from the Krantz product business and the Leppävirta workshop. As we are moving more towards service

Patent granted for MOB-015 in China

STOCKHOLM, November 23rd, 2018, Moberg Pharma AB (OMX: MOB) is pleased to announce that MOB-015 has been granted patent protection in China, valid until 2032. MOB-015 is an internally developed topical formulation of terbinafine for the treatment of onychomycosis, currently under clinical development in phase 3. MOB-015’s patent protection thus covers the key markets for commercialization.The Chinese Patent Office has issued patent no. 201280007874.9 for MOB-015, valid until 2032. The Chinese patent covers an internally developed topical formulation of terbinafine for the treatment of

2cureX AB publishes interim report for January – September 2018

2cureX AB (”2cureX”) hereby publishes the interim report for the first nine months of 2018. The interim report is available via attached file and on the company’s website (www.2curex.com). Below follows a short summary of the interim report.The first nine months (2018-01-01 until 2018-09-30) – the group · Net turnover for the period was 0 KSEK (0 KSEK). · The result after tax was -6,759 KSEK (-3,078 KSEK). · The result per share* was -0.65 SEK (-0.38 SEK). · The solidity** was 51 % (50 %). · The cash and bank were 23,848 KSEK (5,000 KSEK). Third quarter (2018-07-01 till

Dome Energy appoints new CFO

Dome Energy AB  (publ) (herein after “Dome” and/or “the Company”) today announces that the company has appointed Charlotta Nicander as the new CFO located in Stockholm. Charlotta will assume the position at 1:st of December and replace Marianne Brandt. Charlotta has a long and solid background from finance, accounting and control in qualified positions in companies both listed at Nasdaq and private, in particular some 20 years in real estate business. Charlotta has also large experience of management and company board work. Paul Morch, CEO: “We are very

Bulten awarded further Electric Vehicle Drive Technologies FSP contract

Bulten has strengthened its Electric Vehicle FSP (Full Service Provider) Portfolio through the award of a further contract from a major European automotive manufacturer. The contract is initially valued at approximately  EUR 5 million per annum and will launch in 2020 extending for a period of 5 years.“The award of a second Electric Vehicle FSP contract in a short space of time confirms that the approach and expertise Bulten brings to this field is recognised and appreciated by major OEM’S within the automotive industry”, commented Tommy Andersson, President and CEO of Bulten. The main

GROSS PROFIT GROWTH OF 24.5 PERCENT AND SUBSTANTIALLY IMPROVED EBIT

This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version governs.THIRD QUARTER, JULY – SEPTEMBER 2018  · Net sales increased by 22.8% to MSEK 56.0 (45.6) · Gross profit increased by 24.5% to MSEK 41.2 (33.1) · EBIT was MSEK -3.4 (-8.6) · Earnings after tax was MSEK -3.6 (-8.3) · Earnings per share was, basic SEK -0.51 (-1.16), diluted SEK -0.50 (-1.14)                                   NINE MONTHS, JANUARY – SEPTEMBER 2018  · Net sales increased by 17.7% to MSEK 178.5 (151.7) · Gross profit

Fazer Culinary Team Finland’s top chefs to compete for the World Cup on 26 November

Fazer Culinary Team Finland, which won gold at the Culinary Olympics, will be competing in the Culinary World Cup, held in Luxembourg, on Monday 26 November. The team faces the challenging task of preparing lunch for 150 people in the competition’s Catering category. A record number of teams participated in the tight qualifying round, after which 15 teams were accepted into the actual competition.The team has prepared for the competition for two years and practised together for the past 18 months. Their cooperation in the kitchen is seamless. Success demands nothing short of a first-rate

Nyfosa listed on Nasdaq Stockholm

The property company Nyfosa AB is listed on Nasdaq Stockholm today. The shares will be traded in the Large Cap segment under the ticker NYF and the ISIN code SE0011426428. The listing marks the beginning of Nyfosa as an independent company after its distribution to ordinary shareholders in Hemfosa.“We’re pleased and proud that Nyfosa is now listed as an independent company on Nasdaq Stockholm. Nyfosa is a transaction-based property company whose business model offers a new investment alternative in the Swedish property market. Without categorical, geographical or size limits on our strategy,

NPRO - Agreement on sale of Stavanger properties

Norwegian Property has entered into an agreement for the sale of four properties in Forus, Stavanger; Grenseveien 19 and 21, Maskinveien 32 and Svanholmen 2. The buyer is V20 Invest AS, gross property value is NOK 237 million. Badehusgata 33-39 in Stavanger city center is also sold, but NPRO will still own 50% in a joint venture with the buyers Camar Eiendom (35%) and Agera Eiendom (15%). Gross property value is agreed at NOK 280 million. The total property value was NOK 513 million at the end of the third quarter of 2018. This is the last completed external valuation, of which

Starbreeze is reviewing costs and focusing on core business

STOCKHOLM (23 November 2018) – The positive EBITDA target stands for Q4 2018, but not for the full year 2019. The board of directors has given management a mandate to review the cost of operations, and a program to reduce costs and sharpen focus on core business has been initiated. A license fee of USD 10 million from 505 Games for the console version of Overkill’s The Walking Dead will not be recognized as revenue until after the end of the current quarter, which will have negative impact on Starbreeze’s earnings in the fourth quarter.  “We will not be able to recognize the license

Heroes of Warland featured in Google Play Store

Nitro Games’ new game Heroes of Warland has received featuring in Google Play Store in 80 countries. Heroes of Warland was launched on the Google Play Store on Thursday, November 15th. The game has received featuring in Google Play Store in 55 countries on the launch week and in 80 countries this week. These countries include Tier 1 markets such as the United States, Canada, United Kingdom, Germany, France, and Australia. This featuring means that the game has received additional visibility on the Google Play Store in the home view and other categories. The game has also been

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release November 23, 2018, at 8:40 a.m.  Nokian Tyres has received an announcement from BlackRock, Inc. on November 22, 2018, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below level of 5% of the share capital in Nokian Tyres plc, as result of share transactions concluded on November 21, 2018.  Total positions of BlackRock, Inc. and its funds subject to the notification:  +----------------+----------+--------

Loudspring Oyj - Managers' Transactions

Person subject to the notification requirement Name: Vuoria, Matti Position: Member of the Board Issuer: Loudspring Oyj LEI: 74370040F0RYWDWUJC65 Notification type: Initial notification Reference number: 74370040F0RYWDWUJC65_20181122150324_3 ____________________________________________ Transaction date: 2018-11-21 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: Share ISIN: FI4000092523 Nature of the transaction: ACQUISITION Transaction Details (1): Volume: 50000 Unit price: 0,415 EUR Aggregated transactions (1): Volume: 50000 Volume

Enzymatica signs another agreement in Asia with Evergreen for Hong Kong and Macau

Enzymatica has entered into a distribution agreement with healthcare company Evergreen Health Ltd for sales and marketing of ColdZyme® Mouth Spray in Hong Kong and Macau. This is the second contract after Japan in Enzymatica’s expansion into Asia. Product sales are expected to begin in 2019. Evergreen Health Ltd is part of Meiriki, a company that develops and sells various types of dietary supplements for the market in Hong Kong and Macau. Meiriki was founded in 1997 and has about 95 employees. The company, which sells products for vision, joint and cardiac problems, as well as products

Teleste’s smart and safe bus stop built at the Nokia Campus in Espoo, Finland, as a part of the LuxTurrim5G ecosystem

Turku, Finland – 23 November 2018 – Teleste has built a smart and safe bus stop at the Nokia Campus in Espoo, Finland, as a part of the LuxTurrim5G ecosystem. The innovative bus stop has been designed to improve safety and security for public places through Teleste’s newly launched Connected Zone  concept that was introduced in October during Teleste’s Security Seminar in Sweden, where the concept will continue to be developed and tested as a part of Teleste’s Smart City offering. By means of video surveillance and high-capacity 5G connectivity, the smart and

BLACKPEARL PROVIDES UPDATE ON UPCOMING SPECIAL MEETING OF SECURITYHOLDERS

CALGARY, ALBERTA, November 22, 2018 /CNW/ – BlackPearl Resources Inc. ("BlackPearl") (TSX: PXX, Nasdaq Stockholm: PXXS) wishes to advise that the meeting materials for the upcoming special meeting of securityholders scheduled to take place on Friday, December 7, 2018 were mailed to registered securityholders in accordance with the previously granted court order. Because of the ongoing rotating strikes by Canada Post employees across Canada and the reported backlog of mail in parts of the Canadian postal system, there may be some uncertainty as to the timing of the delivery of the meeting

Picosun Group reports significant increase in turnover and profitability

ESPOO, Finland, 23rd November 2018 – Picosun Group, a leading provider of advanced ALD (Atomic Layer Deposition) thin film coating technology for global industries, reports 37 % rise in turnover to 25.96 million euros during its previous fiscal year, which ended 30th September 2018. At the same time, the company increased its profitability. EBIT grew to 1.42 million euros which equals 5.5 % of turnover, and EBITDA to 2.39 million euros which is 9.2 % of turnover. The numbers are still unconfirmed. Picosun’s personnel grew one third to 86 people. Almost 25 % of the personnel have

Smile – and the rest will follow

Fotografiska For Life/Jörgen Hildebrandt  22 November – 3 February 2019 Fotografiska Face the world with a smile and it smiles back at you. Smile and the rest will follow… But what if your face is seen as a sign that you've been cursed – and instead you're faced with fear, ridicule and ostracism? This is the reality for many children born with cleft lip and cleft palate (CLP).  A simple operation that can take less than an hour completely change someone's life. 22th November will see the opening of Smile – and the rest will follow, a new Fotografiska For Life exhibition wherein Jörgen

Borr Drilling Limited (BDRILL) – Purchase of own shares

Borr Drilling Limited (the “Company”) has today purchased 200,000 of its own shares at an average price of NOK 28.0106 per share. The share purchase has been carried out in connection with the share repurchase program announced by the Company on 28 August 2018. After this transaction the Company holds 4,298,572 of its own shares in treasury. 22 November 2018 Hamilton, Bermuda This information is subject to disclosure requirements pursuant to Sections 4-2 and 5-12 of the Norwegian Securities Trading Act.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 22.11.2018

Fiskars Corporation  NOTIFICATION 22.11.2018 at 18:30 EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 22.11.2018 Date 22.11.2018Exchange transaction BuyShare class FSKRSAmount       1 500 Average price/share 16.1592  EUR  Highest price/share 16.2000 EUR Lowest price/share 16.1000 EUR Total price 24,238.80  EUR  The shares held by Fiskars Corporation on 22.11.2018: FSKRS 299,560  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Janne Tiihonen

Asarina Pharma CSO presents at PMS event in Stockholm: ‘It’s time to talk about PMDD’

Torbjörn Bäckström, Asarina Pharma CSO, and Karin Ekberg, COO, spoke at PMS & PMDD Day on November 21, at Medelhavsmuseet, Stockholm. A wide range of PMS researchers, educators and activists took part. “It’s fantastic to see this billed as PMS and PMDD Day,” says Asarina Pharma CEO Peter Nordkild. “It shows how much knowledge of PMDD as a diagnosis and condition is spreading fast.”The event began with Lisa Stenberg, author of the best-selling Bli vän med din PMS (Make friends with your PMS). Lisa emphasized the importance of keeping a menstrual diary to better understand and manage symptoms.

There are no items matching the current filter
There are no more items matching the current filter
Back to top